496 related articles for article (PubMed ID: 20941528)
1. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.
Panigrahy D; Kaipainen A; Greene ER; Huang S
Cancer Metastasis Rev; 2010 Dec; 29(4):723-35. PubMed ID: 20941528
[TBL] [Abstract][Full Text] [Related]
2. EET signaling in cancer.
Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
[TBL] [Abstract][Full Text] [Related]
3. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
4. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
5. Regulation of inflammation in cancer by eicosanoids.
Greene ER; Huang S; Serhan CN; Panigrahy D
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):27-36. PubMed ID: 21864702
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
7. Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation.
Anwar-mohamed A; Zordoky BN; Aboutabl ME; El-Kadi AO
Pharmacol Res; 2010 May; 61(5):410-8. PubMed ID: 20045729
[TBL] [Abstract][Full Text] [Related]
8. Regulation of inflammation in cancer by dietary eicosanoids.
Yang H; Rothenberger E; Zhao T; Fan W; Kelly A; Attaya A; Fan D; Panigrahy D; Deng J
Pharmacol Ther; 2023 Aug; 248():108455. PubMed ID: 37257760
[TBL] [Abstract][Full Text] [Related]
9. Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy.
ElKhatib MAW; Isse FA; El-Kadi AOS
Drug Metab Rev; 2023; 55(1-2):50-74. PubMed ID: 36573379
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.
Johnson AL; Edson KZ; Totah RA; Rettie AE
Adv Pharmacol; 2015; 74():223-62. PubMed ID: 26233909
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 pathways of arachidonic acid metabolism.
Kroetz DL; Zeldin DC
Curr Opin Lipidol; 2002 Jun; 13(3):273-83. PubMed ID: 12045397
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
Huang H; Al-Shabrawey M; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():45-53. PubMed ID: 26747234
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of arachidonic acid by rat adrenal glomerulosa cells: synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids.
Campbell WB; Brady MT; Rosolowsky LJ; Falck JR
Endocrinology; 1991 Apr; 128(4):2183-94. PubMed ID: 1900788
[TBL] [Abstract][Full Text] [Related]
14. A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue.
Yue H; Jansen SA; Strauss KI; Borenstein MR; Barbe MF; Rossi LJ; Murphy E
J Pharm Biomed Anal; 2007 Feb; 43(3):1122-34. PubMed ID: 17125954
[TBL] [Abstract][Full Text] [Related]
15. Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions.
Stoltz RA; Conners MS; Dunn MW; Schwartzman ML
J Ocul Pharmacol; 1994; 10(1):307-17. PubMed ID: 8207335
[TBL] [Abstract][Full Text] [Related]
16. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F
Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604
[TBL] [Abstract][Full Text] [Related]
17. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
18. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.
Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature.
Kiss L; Schütte H; Mayer K; Grimm H; Padberg W; Seeger W; Grimminger F
Am J Respir Crit Care Med; 2000 Jun; 161(6):1917-23. PubMed ID: 10852767
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
